Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial

Zev A. Wainberg, Gulam A. Manji, Nathan Bahary, Susanna V. Ulahannan, Shubham Pant, David R. Spigel, Nataliya V. Uboha, Paul E. Oberstein, Anwaar Saeed, Brandon Beagle, Ji Yun Kim, Ning Wang, Ben Weeder, Shravani Shitole, Karim Mrouj, Jennifer R. Scott, Lisa G. Ensign, Daniel M. DiRenzo, Matthew J. Walters, Wilson Wu, Angelo Kaplan, Soonweng Cho, Omar Kabbarah, Eileen M. O’Reilly

Open source

DOI: 10.1038/s41591-026-04283-z
Published: 2026-03-30
Container: Nature Medicine
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41591-026-04283-z,
  title = {Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial},
  author = {Zev A. Wainberg and Gulam A. Manji and Nathan Bahary and Susanna V. Ulahannan and Shubham Pant and David R. Spigel and Nataliya V. Uboha and Paul E. Oberstein and Anwaar Saeed and Brandon Beagle and Ji Yun Kim and Ning Wang and Ben Weeder and Shravani Shitole and Karim Mrouj and Jennifer R. Scott and Lisa G. Ensign and Daniel M. DiRenzo and Matthew J. Walters and Wilson Wu and Angelo Kaplan and Soonweng Cho and Omar Kabbarah and Eileen M. O’Reilly},
  year = {2026},
  journal = {Nature Medicine},
  doi = {10.1038/s41591-026-04283-z},
  url = {https://doi.org/10.1038/s41591-026-04283-z}
}

RIS

TY  - JOUR
TI  - Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial
AU  - Zev A. Wainberg
AU  - Gulam A. Manji
AU  - Nathan Bahary
AU  - Susanna V. Ulahannan
AU  - Shubham Pant
AU  - David R. Spigel
AU  - Nataliya V. Uboha
AU  - Paul E. Oberstein
AU  - Anwaar Saeed
AU  - Brandon Beagle
AU  - Ji Yun Kim
AU  - Ning Wang
AU  - Ben Weeder
AU  - Shravani Shitole
AU  - Karim Mrouj
AU  - Jennifer R. Scott
AU  - Lisa G. Ensign
AU  - Daniel M. DiRenzo
AU  - Matthew J. Walters
AU  - Wilson Wu
AU  - Angelo Kaplan
AU  - Soonweng Cho
AU  - Omar Kabbarah
AU  - Eileen M. O’Reilly
PY  - 2026
JO  - Nature Medicine
DO  - 10.1038/s41591-026-04283-z
UR  - https://doi.org/10.1038/s41591-026-04283-z
ER  -

APA

Wainberg, Z. A., Manji, G. A., Bahary, N., Ulahannan, S. V., Pant, S., Spigel, D. R., Uboha, N. V., Oberstein, P. E., Saeed, A., Beagle, B., Kim, J. Y., Wang, N., Weeder, B., Shitole, S., Mrouj, K., Scott, J. R., Ensign, L. G., DiRenzo, D. M., Walters, M. J., Wu, W., Kaplan, A., Cho, S., Kabbarah, O., & O’Reilly, E. M. (2026). Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial. Nature Medicine. https://doi.org/10.1038/s41591-026-04283-z

Source records

crossref · retrieved 2026-09-26T10:43:17.710Z